Proline homozygosity in codon 72 of p53: A risk genotype for human papillomavirus related cervical cancer in Indian women

Cancer Letters

Volumn 188, Issue 1-2, 2002, Pages 207-211

  Bhattacharya, Paramita ^a   Duttagupta, Chandralekha ^a   Sengupta, Sharmila ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Cervical cancer; Human papillomavirus; p53 Polymorphism at codon 72; Proline homozygosity

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; DNA ISOLATION; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CODON; DNA, NEOPLASM; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; INDIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROLINE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0037114347     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00430-5     Document Type: Article

References (27)

1. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J.F., Peto J., Meijer C.J.L.M., Munoz N. Human papillomavirus is a necessary cause of invasive CaCx worldwide. J. Pathol. 189:1999;12-19.
2. Storey A., Thomas M., Kalita A., Harwood C., Gardio D., Mantovani F., Breuer J., Leigh I.M., Matlashewski G., Banks L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 393:1998;229-234.
3. Jin X., Wu X., Roth J.A., Amos C.I., King T.M., Branch C., Honn S.E., Spitz M.R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 16:1995;2205-2208.
4. Rosenthal A.N., Ryan A., Hopster D., Jacobs I.J. p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia. Br. J. Cancer. 83:2000;1287-1290.
5. Thomas M., Kalita A., Labrecque S., Pim D., Banks L., Matlashewski G. Two polymorphic variants of wild type p53 differ biochemically and biologically. Mol. Cell. Biol. 19:1999;1092-1100.
6. Minaguchi T., Kanamori Y., Matsushima M., Yoshikawa H., Taketani Y., Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 58:1998;4585-4586.
7. Rosenthal A.N., Ryan A., Al-Jehani R.M., Storey A., Harwood C.A., Jacobs I.J. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet. 352:1998;871-872.
8. Lanham S., Campbell I., Watt P., Gornall R. p53 polymorphism and risk of cervical cancer. Lancet. 352:1998;1631.
9. Hayes V.M., Hofstra R.M.W., Buys C.H., Hollema H., van der Zee A.G. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet. 352:1998;1756.
10. Josefsson A.M., Magnusson P.K.E., Ylitalo N., Quarforth-Tubbin P., Ponten J., Adami H.O., Gyllensten U.B. p53 polymorphism and risk of cervical cancer. Nature. 396:1998;531.
11. Helland A., Langerod A., Johnsen H., Olsen A.O., Skovlund E., Borresen-Dale A.L. p53 polymorphism and risk of cervical cancer. Nature. 396:1998;530-531.
12. Yamashita T., Yaginuma Y., Saitoh Y., Kawai K., Kurakane T.Q., Hayashi H., Ishikawa M. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis. 20:1999;1733-1736.
13. Zehbe I., Voglino G., Wilander E., Genta F., Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet. 354:1999;218-219.
14. Agorastos T., Lambropoulos A.F., Constantinidis T.C., Kotsis A., Bontis J.N. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur. J. Cancer Prev. 9:2000;113-118.
15. Miller S.A., Dykes D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
16. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Furth M., Greaves M.F., Molecular Diagnostics of Human Cancer. 1989;209-214 Cold Spring Harbor Laboratory Press, New York, NY.
17. Haraf D.J., Nodzenski E., Brachman D., Mick R., Montag A., Graves D., Vokes E.E., Weichselbaum R.R. Human papillomavirus and p53 in head and neck cancer: clinical correlates and survival. Clin. Cancer Res. 2:1996;755-762.
18. Altman D.G. Practical Statistics for Medical Research. 1990;268-270 Chapman and Hall, New York, NY.
19. Wang Y.-C., Chen C.-Y., Chen S.-K., Chang Y.-Y., Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin.Cancer Res. 1999;129-134.
20. Kim J.W., Lee C.G., Park Y.G., Kim K.S., Kim I.K., Sohn Y.W., Min H.K., Lee J.M., Namkoong S.E. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer (Phila.). 88:2000;2082-2091.
21. Tandle A.T., Sanghvi V., Sarnath D. Determination of p53 genotypes in oral cancer patients from India. Br. J. Cancer. 84:2001;739-742.
22. Beckman G., Birgander R., Sjalander A., Saha N., Holmberg A., Kivela P.A., Beckman L. Is p53 polymorphism maintained by natural selection? Hum. Hered. 44:1994;266-270.
23. Hildesheim A., Schiffman M., Brinton L.A., Fraumeni J.F. Jr, Herrero R., Bratti M.C., Schwartz P., Mortel R., Barnes W., Greenberg M., McGowan L., Scott D.R., Martin M., Herrera J.E., Carrington M. p53 polymorphism and risk of cervical cancer. Nature. 396:1998;531-532.
24. Birgander R., Sjalander A., Rannug A., Alexandrie A.K., Sundberg M.I., Seidegard J., Tornling G., Beckman G., Beckman L. p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis. 16:1995;2233-2236.
25. Birgander R., Sjalander A., Zhou Z., Fan C., Beckman L., Beckman G. p53 polymorphism and haplotypes in nasopharyngeal cancer. Hum. Hered. 46:1996;49-54.
26. van Duin M., Snijders P.J.F., Vossen M.T.M., Klaassen E., Voorhorst F., Verheijen R.H.M., Helmerhorst T.J., Meijer C.J.L.M., Walboomers J.M.M. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J. Gen. Virol. 81:2000;317-325.
27. Duttagupta C., Sengupta S., Roy M., Sengupta D., Chakraborty S., Bhattacharya P., Roy S., Ghosh S. Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer: a screening strategy in the perspective of rural India. Eur. J. Cancer Prev. 2002;(in press).